<?xml version="1.0" encoding="windows-1252"?><output><s i="0"><ENAMEX ID="0" TYPE="ORGANIZATION">Justice Agency</ENAMEX> Investigates Charges Against <ENAMEX ID="1" TYPE="ORGANIZATION">Grace</ENAMEX>..</s>
<s i="1"><ENAMEX ID="2" TYPE="ORGANIZATION">BOCA RATON</ENAMEX>, <ENAMEX ID="3" TYPE="LOCATION">Fla.</ENAMEX> -- <ENAMEX ID="4" TYPE="LOCATION">The U.S.</ENAMEX></s>
<s i="2"><ENAMEX ID="5" TYPE="ORGANIZATION">Justice Department</ENAMEX> is investigating allegations made in a so-called whistle-blower lawsuit that <ENAMEX ID="6" TYPE="ORGANIZATION">W.R.</ENAMEX></s>
<s i="3"><ENAMEX ID="7" TYPE="ORGANIZATION">Grace &amp; Co.</ENAMEX>'s <ENAMEX ID="8" TYPE="ORGANIZATION">National Medical Care</ENAMEX> unit fraudulently billed Medicare, resulting in government losses of over $200 million.</s>
<s i="4">The suit, originally filed under seal in <ENAMEX ID="4" TYPE="LOCATION">The U.S.</ENAMEX></s>
<s i="5"><ENAMEX ID="9" TYPE="ORGANIZATION">District Court</ENAMEX> for the <ENAMEX ID="10" TYPE="ORGANIZATION">Southern District of Florida</ENAMEX> in 2009, was disclosed this month in a <ENAMEX ID="1" TYPE="ORGANIZATION">Grace</ENAMEX> filing with the <ENAMEX ID="11" TYPE="ORGANIZATION">Securities and Exchange Commission</ENAMEX>.</s>
<s i="6">The whistle-blower suit-filed by a former or current Grace employee-alleges that <ENAMEX ID="12" TYPE="ORGANIZATION">NMC</ENAMEX> fraudulently treated its Medicare billings for <ENAMEX ID="13" TYPE="PERSON">Epogen</ENAMEX>, an anemia drug used in <ENAMEX ID="12" TYPE="LOCATION">NMC</ENAMEX>'s kidney dialysis business.</s>
<s i="7"><ENAMEX ID="1" TYPE="ORGANIZATION">Grace</ENAMEX> said in the filing that it became aware of the allegations last month when the suit was ``partially'' unsealed.</s>
<s i="8">That action was taken so that <ENAMEX ID="1" TYPE="ORGANIZATION">Grace</ENAMEX> could disclose the suit to <ENAMEX ID="14" TYPE="ORGANIZATION">Fresenius AG</ENAMEX> of <ENAMEX ID="15" TYPE="LOCATION">Germany</ENAMEX>, which has agreed to acquire <ENAMEX ID="12" TYPE="ORGANIZATION">NMC</ENAMEX> in a tax-free spinoff.</s>
<s i="9"><ENAMEX ID="1" TYPE="ORGANIZATION">Grace</ENAMEX> shareholders will vote May 29, 2011 that spinoff, through which <ENAMEX ID="12" TYPE="ORGANIZATION">NMC</ENAMEX> will make a $2.3 billion cash payment to <ENAMEX ID="1" TYPE="ORGANIZATION">Grace</ENAMEX>.</s>
<s i="10">A <ENAMEX ID="1" TYPE="ORGANIZATION">Grace</ENAMEX> spokeswoman said the whistle-blower suit won't affect the planned spinoff.</s>
<s i="11">Fresenius declined to comment.</s>
<s i="12"><ENAMEX ID="12" TYPE="ORGANIZATION">NMC</ENAMEX>, based in <ENAMEX ID="16" TYPE="LOCATION">Waltham</ENAMEX>, <ENAMEX ID="17" TYPE="LOCATION">Mass.</ENAMEX>, has been under investigation by <ENAMEX ID="5" TYPE="ORGANIZATION">Justice Department</ENAMEX> and <ENAMEX ID="4" TYPE="LOCATION">The U.S.</ENAMEX></s>
<s i="13"><ENAMEX ID="18" TYPE="ORGANIZATION">Health and Human Services Department</ENAMEX> since the fall.</s>
<s i="14">The company's dialysis business is also the subject of a federal grand jury inquiry in <ENAMEX ID="19" TYPE="LOCATION">Virginia</ENAMEX>.</s>

</output>